PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
14% Plai cream showed a strong trend of benefits in pain reduction [PMID:29154071].
14% Plai cream substantially reduced muscle soreness over 7 days by -82% compared to placebo [PMID:26988432].
Patients using 15% w/w Plai balm showed statistically significant lesser mean pain scores than the placebo group at week two and week four [PMID:39220605].
Evidence supporting effects in these areas remains unclear [PMID:29154071].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 29154071 (2017) — Clinical effects of Zingiber cassumunar (Plai): A systematic review. · Complementary therapies in medicine
- 2.PMID: 33921835 (2021) — Phytochemicals and Bioactivities of Zingiber cassumunar Roxb. · Molecules (Basel, Switzerland)
- 3.PMID: 26988432 (2016) — Effects of Zingiber cassumunar (Plai cream) in the treatment of delayed onset muscle soreness. · Journal of integrative medicine
- 4.PMID: 39220605 (2023) — Effect of topical Zingiber cassumunar on painful diabetic neuropathy: a double-blind randomized-controlled trial. · F1000Research
- 5.PMID: 38542853 (2024) — Characterization of the Volatile Constituents of Plai (Zingiber purpureum) by Gas Chromatography-Mass Spectrometry.